Patricia Seitz, PhD
Advertisement
Articles by Patricia Seitz, PhD
Advertisement
Latest Updated Articles
- Economic Outcomes of a Targeted Intervention Program: The Costs of Treating Allergic Rhinitis Patients
Published: April 1st 1999 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
4
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
5
